BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer.

被引：0
|
作者：
Bridgewater, J. A.
Stubbs, C.
Primrose, J. N.
机构：
[1] UCL, London, England
[2] Canc Res UK Clin Trials Unit CRCTU, Birmingham, W Midlands, England
[3] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4126
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
    O. Nanni
    D. Amadori
    A. De Censi
    A. Rocca
    A. Freschi
    A. Bologna
    L. Gianni
    F. Rosetti
    L. Amaducci
    L. Cavanna
    F. Foca
    S. Sarti
    P. Serra
    L. Valmorri
    P. Bruzzi
    D. Corradengo
    A. Gennari
    Breast Cancer Research and Treatment, 2019, 174 : 433 - 442
  • [42] A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer.
    Fehrenbacher, L.
    O'Neill, V.
    Belani, C. P.
    Bonomi, P.
    Hart, L.
    Melnyk, O.
    Sandler, A.
    Ramies, D.
    Herbst, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [43] A randomized phase II trial of adjuvant chemotherapy with cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG regimen) or gemcitabine alone after curative resection for pancreatic cancer
    Reni, M.
    Cereda, S.
    Aprile, G.
    Tronconi, M. C.
    Milandri, C.
    Passoni, P.
    Rognone, A.
    Balzano, G.
    Di Carlo, V.
    Villa, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] Examination of sleep and fatigue at baseline and after the first adjuvant breast cancer chemotherapy treatment within a randomized clinical trial
    Berger, AM
    Kildare, C
    Farr, L
    Kuhn, B
    SLEEP, 2005, 28 : A292 - A292
  • [45] Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial
    Nomura, Hiroyuki
    Aoki, Daisuke
    Susumu, Nobuyuki
    Mizuno, Mika
    Nakai, Hidekatsu
    Arai, Masahide
    Nishio, Shin
    Tokunaga, Hideki
    Nakanishi, Toru
    Watanabe, Yoh
    Yaegashi, Nobuo
    Yokoyama, Yoshihito
    Takehara, Kazuhiro
    GYNECOLOGIC ONCOLOGY, 2019, 155 (03) : 413 - 419
  • [46] A randomized controlled trial comparing zoledronic acid plus chemotherapy with chemotherapy alone as a neoadjuvant treatment in patients with HER2-negative primary breast cancer.
    Horiguchi, Jun
    Hasegawa, Yoshie
    Miura, Daishu
    Ishikawa, Takashi
    Hayashi, Mitsuhiro
    Takao, Shintaro
    Kim, Seung Jin
    Tanino, Hirokazu
    Miyashita, Masaru
    Konishi, Muneharu
    Shigeoka, Yasushi
    Yamagami, Kazuhiko
    Akazawa, Kohei
    Kohno, Norio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Quality of Life After Adjuvant Intra-Arterial Chemotherapy and Radiotherapy Versus Surgery Alone in Resectable Pancreatic and Periampullary Cancer. A Prospective Randomized Controlled Study
    Morak, Marjolein
    Pek, Chulja
    Kompanje, Erwin J.
    Hop, Wim C.
    Kazemier, Geert
    van Eijck, Casper H.
    GASTROENTEROLOGY, 2009, 136 (05) : A487 - A487
  • [48] A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer - GRECCAR 15 trial protocol
    Denost, Quentin
    Frison, Eric
    Salut, Cecile
    Sitta, Remy
    Rullier, Anne
    Harji, Deena
    Maillou-Martinaud, Helene
    Rullier, Eric
    Smith, Denis
    Vendrely, Veronique
    COLORECTAL DISEASE, 2021, 23 (07) : 1909 - 1918
  • [49] Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial
    Ayez, Ninos
    van der Stok, Eric P.
    de Wilt, Hans
    Radema, Sandra A.
    van Hillegersberg, Richard
    Roumen, Rudi M.
    Vreugdenhil, Gerard
    Tanis, Pieter J.
    Punt, Cornelis J.
    Dejong, Cornelis H.
    Jansen, Rob L.
    Verheul, Henk M.
    de Jong, Koert P.
    Hospers, Geke A.
    Klaase, Joost M.
    Legdeur, Marie-Cecile
    van Meerten, Esther
    Eskens, Ferry A.
    van der Meer, Nelly
    van der Holt, Bruno
    Verhoef, Cornelis
    Grunhagen, Dirk J.
    BMC CANCER, 2015, 15
  • [50] Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial
    Ninos Ayez
    Eric P van der Stok
    Hans de Wilt
    Sandra A Radema
    Richard van Hillegersberg
    Rudi M Roumen
    Gerard Vreugdenhil
    Pieter J Tanis
    Cornelis J Punt
    Cornelis H Dejong
    Rob L Jansen
    Henk M Verheul
    Koert P de Jong
    Geke A Hospers
    Joost M Klaase
    Marie-Cecile Legdeur
    Esther van Meerten
    Ferry A Eskens
    Nelly van der Meer
    Bruno van der Holt
    Cornelis Verhoef
    Dirk J Grünhagen
    BMC Cancer, 15
12345